Abstract

Olfactory bulb SARS-CoV-2 infection is not paralleled by the presence of virus in other central nervous system areas.

Highlights

  • A number of post-mortem neuropathological studies have reported vascular, thrombotic, and ischaemic alterations in COVID-19 cases [10,11,12,13,14,15,16]

  • The presence of SARS-CoV-2 within central nervous system (CNS) specimens was reported to range between 0% and 53% of analysed cases across studies, including the olfactory bulbs and/or cerebral parenchyma [12,13,14,15,16]

  • Our group aimed to describe the neuropathological findings in SARS-CoV-2 infected patients who died during the COVID-19 pandemic, and, by using RT-PCR and immunohistochemistry (IHC), to define and quantify the presence of virus in selected areas showing pathological signs, as well as in areas of interest that might define a route of spread for the virus in the CNS

Read more

Summary

Introduction

A number of post-mortem neuropathological studies have reported vascular, thrombotic, and ischaemic alterations in COVID-19 cases [10,11,12,13,14,15,16]. The presence of SARS-CoV-2 within CNS specimens was reported to range between 0% and 53% of analysed cases across studies, including the olfactory bulbs and/or cerebral parenchyma [12,13,14,15,16].

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.